980USD
3.08
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.87
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-15.686
Wall Street Target Price
21.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
659,000
Gross Profit TTM
-20,985,000
EBITDA
-29,295,000
Profit Margin
0.00%
Return On Assets TTM
-41.86%
Return On Equity TTM
-192.97%
Revenue Per Share TTM
0.187
Qtly Revenue Growth YOY
-48.80%
Diluted Eps TTM
-15.686
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.0015
Price Book MRQ
0.0001
Enterprise Value Revenue
4
Enterprise Value EBITDA
0
19.87
4.58%75.91
2.93%47.22
2.92%61.05
2.87%25.94
1.29%91.10
1.01%615.99
0.57%288.00
0.56%468.75
0.42%250.00
0.29%